Treatment of mycobacterium abscessus infection

Shannon A. Novosad; Susan E. Beekmann; Philip M. Polgreen; Kate Mackey; Kevin L. Winthrop

doi:10.3201/eid2203.150828

Treatment of mycobacterium abscessus infection

Shannon A. Novosad, Susan E. Beekmann, Philip M. Polgreen, Kate Mackey, Kevin L. Winthrop

School Of Public Health

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Abstract

Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.

Original language	English (US)
Pages (from-to)	511-514
Number of pages	4
Journal	Emerging infectious diseases
Volume	22
Issue number	3
DOIs	https://doi.org/10.3201/eid2203.150828
State	Published - Mar 2016

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3201/eid2203.150828

Cite this

@article{f215235568024fb79c0654452d2031ff,

title = "Treatment of mycobacterium abscessus infection",

abstract = "Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.",

author = "Novosad, {Shannon A.} and Beekmann, {Susan E.} and Polgreen, {Philip M.} and Kate Mackey and Winthrop, {Kevin L.}",

year = "2016",

month = mar,

doi = "10.3201/eid2203.150828",

language = "English (US)",

volume = "22",

pages = "511--514",

journal = "Emerging infectious diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "3",

}

TY - JOUR

T1 - Treatment of mycobacterium abscessus infection

AU - Novosad, Shannon A.

AU - Beekmann, Susan E.

AU - Polgreen, Philip M.

AU - Mackey, Kate

AU - Winthrop, Kevin L.

PY - 2016/3

Y1 - 2016/3

N2 - Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.

AB - Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.

UR - http://www.scopus.com/inward/record.url?scp=84958760756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958760756&partnerID=8YFLogxK

U2 - 10.3201/eid2203.150828

DO - 10.3201/eid2203.150828

M3 - Article

C2 - 26890211

AN - SCOPUS:84958760756

SN - 1080-6040

VL - 22

SP - 511

EP - 514

JO - Emerging infectious diseases

JF - Emerging infectious diseases

IS - 3

ER -

Treatment of mycobacterium abscessus infection

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this